Understanding how vaginal washing affects cervical health and HIV risk
The impact of vaginal washing on cervical inflammation: a randomized controlled trial of women from sub-Saharan Africa at high risk for HIV acquisition.
This project explores if stopping vaginal washing can improve vaginal health and reduce the chance of getting HIV for women in sub-Saharan Africa.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11193425 on NIH RePORTER |
What this research studies
Many women use vaginal washing, believing it is hygienic, but it has been linked to health issues, including a higher chance of getting HIV. This project aims to discover if stopping vaginal washing can reduce inflammation in the cervix and improve the natural protective bacteria in the vagina. Researchers believe that vaginal washing might cause inflammation and disrupt the body's natural defenses, making women more vulnerable to HIV. This project will compare women who stop vaginal washing with those who continue, looking for changes in vaginal fluid and tissue to see if these changes could lower the risk of HIV.
Who could benefit from this research
Good fit: Ideal candidates are women from sub-Saharan Africa who currently practice vaginal washing and are at high risk for HIV acquisition.
Not a fit: Patients who do not practice vaginal washing or are not at risk for HIV acquisition may not directly benefit from this specific intervention.
Why it matters
Potential benefit: If successful, this project could provide clear guidance on vaginal washing practices to help women reduce their risk of HIV and improve their reproductive health.
How similar studies have performed: While previous studies on vaginal washing and HIV risk have had mixed results regarding microbiota disruption, preliminary findings from this team suggest a link between washing and inflammation, which is a novel angle.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Sabo, Michelle Catherine — University of Washington
- Study coordinator: Sabo, Michelle Catherine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.